MedPath

A Retrospective Study on the Effectiveness and Safety of Macrogol 4000, Sodium Chloride, Sodium Bicarbonate, and Potassium Chloride in Pregnant Women with Chronic Constipatio

Not Applicable
Conditions
Chronic Constipation
Registration Number
JPRN-UMIN000046499
Lead Sponsor
Juntendo University Nerima Hospital Department of Obstetrics and Gynecology
Brief Summary

The administration of macrogol preparations to pregnant women with chronic constipation resulted in a significant increase in the frequency of bowel movements 4 weeks after administration , and the effect continued until 8 weeks. In addition, chronic constipation symptoms such as straining and stool hardness improved after 4 weeks, and the effect continued until the end of treatment. Adverse events, side effects and safety issues were not confirmed.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
36
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who have history of Macrogol allergies Patiants who have presence or suspicion of Intestinal obstruction , Intestinal perforation, Severe Inflammatory bowel disease(Ulcerative colitis, Crohn's disease, toxic megacolon) Patiants who have presence or suspicion of organic constipation Patients who received the Macrogol preparation outside the approved dosage and administration

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath